Movement Alert|Cenovus Rises 3.34% in Regular Trading, Q2 Earnings Beat Continues to Fuel Rally

Market Focus07-31

On July 31, Cenovus rose 3.34% in regular trading, trading at $30.045/share, with turnover of $97.76 million. The stock continues to advance as the market digests better-than-expected second-quarter results released on July 29, compounded by a fresh analyst price target upgrade.

Cenovus reported Q2 earnings per share of $1.53, beating the analyst consensus estimate of $1.37 by 11.68% and representing a 240% year-over-year increase. Revenue came in at CA$17.4 billion, surpassing the FactSet estimate of CA$16.87 billion. Prior to the earnings release, the stock had declined for several consecutive sessions amid sector-wide weakness and cautious pre-report sentiment. On July 30, RBC Capital Markets raised its price target on the stock to C$51 from C$47, maintaining an Outperform rating, further reinforcing bullish momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment